Cost-effectiveness and quality- of- life assessment of GM-CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute myeloid leukaemia

Carin Uyl - de Groot, Bob Löwenberg, E Vellenga, S Suciu, R Willemze, FFH Rutten

Research output: Contribution to journalArticleAcademicpeer-review

58 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)629-636
Number of pages8
JournalBritish Journal of Haematology
Volume100
Publication statusPublished - 1998

Research programs

  • EUR ESHPM 02

Cite this